Registered entities
Seraxis, Inc.
Reg. No. 46-2079786United States
Innovation
6 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 483 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 4 |
Social engagement
Social engagement: 1.4K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Lilly, Medytox, ASAP Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 1 | 8% |
| Accelerator & incubator | 3 | 25% |
| Other / undisclosed | 3 | 25% |
Recent activity
1 Aug 2025
Event
World Transplant Congress (WTC)